Compass Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Mar2019 Dec2019 Mar2020 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -0.04M-34.74M-0.04M-29.50M-82.18M-39.23M-42.49M-56.62M
Depreciation and Depletion 0.60M0.80M0.70M0.60M
Share-based Compensation 0.92M4.02M4.03M5.33M6.12M8.56M
Gains from Sales and Divestitures 0.30M0.53M
Gains from Investment Securities 0.06M0.29M5.15M0.07M7.88M14.06M
Non-cash Items 0.01M0.58M
Cash from Operations -0.03M-31.74M-0.03M-26.80M-19.67M-34.12M-40.62M-44.85M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.06M1.12M1.19M1.16M
Amortization of Deferred Charges 0.04M-0.80M-3.23M-1.65M
Depreciation & Amortization (CF) 2.12M2.40M0.57M0.78M0.70M0.59M
Change in Working Capital
Change in Account Payables -1.10M0.43M-0.19M2.52M0.71M-1.84M
Change in Accured Expenses 0.00M0.51M0.01M-1.55M7.02M2.92M-9.18M3.77M
Other Working Capital Changes -0.43M2.19M-1.11M5.59M-6.76M4.86M
Investing Activities
Capital Expenditures 0.47M0.11M1.57M0.21M0.03M0.04M
Sales of Property, Plant and Equipment 0.14M0.12M0.18M
Acquisitions 0.32M
Change in Acquisitions & Divestments 48.95M182.41M134.97M
Cash from Investing Activities -0.47M0.04M-1.77M-151.20M26.96M46.77M
Financing Activities
Other financing activities 6.32M0.28M0.49M-0.16M0.54M
Cash from Financing Activities 0.04M0.03M48.54M118.61M75.76M2.94M17.34M
Additional items
Change in Cash 0.00M-32.21M-0.00M21.77M97.17M-109.57M-10.72M19.25M
Free Cash Flow -0.03M-32.21M-0.03M-26.91M-21.23M-34.34M-40.65M-44.90M
Net Cash Flow 0.00M-32.21M-0.00M21.77M97.17M-109.57M-10.72M19.25M